E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2006 in the Prospect News Bank Loan Daily, Prospect News Biotech Daily and Prospect News High Yield Daily.

S&P assigns Millipore notes BBB-

Standard & Poor's said it assigned its debt and recovery ratings to Millipore Corp.'s €250 million notes offering due in 2016.

The agency said that the debt rating on the notes is BBB-, one notch higher than the BB+ corporate credit rating on Millipore and the recovery rating is 1.

The rating reflects the significantly expanded debt burden incurred to fund the $1.4 billion cash acquisition of Serologicals Corp., the uncertain integration success and, over the longer term, the potential for additional debt-financed acquisitions, according to the agency.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.